PR5-LL-CM01
an inhibitor of protein arginine methyltransferase 5 (PRMT5); has antineoplastic activity
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Amaro, Rommie:
1 article
(06/2017)
|
2. | Chen, Lan:
1 article
(06/2017)
|
3. | Demir, Özlem:
1 article
(06/2017)
|
4. | Fishel, Melissa:
1 article
(06/2017)
|
5. | Korc, Murray:
1 article
(06/2017)
|
6. | Lu, Tao:
1 article
(06/2017)
|
7. | Mo, Jessica:
1 article
(06/2017)
|
8. | Prabhu, Lakshmi:
1 article
(06/2017)
|
9. | Safa, Ahmad:
1 article
(06/2017)
|
10. | Sandusky, George:
1 article
(06/2017)
|
Related Diseases
Related Drugs and Biologics